Single and Dual Targeting of Mutant EGFR with an Allosteric Inhibitor
Allosteric kinase inhibitors offer a potentially complementary therapeutic strategy to ATP-competitive kinase inhibitors due to their distinct sites of target binding. In this study, we identify and study a mutant-selective EGFR allosteric inhibitor, JBJ-04-125-02, which as a single agent can inhibi...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
格式: | Artigo |
语言: | 英语 |
出版: |
2019
|
在线阅读: | https://doi.org/10.1158/2159-8290.cd-18-0903 https://cancerdiscovery.aacrjournals.org/content/candisc/9/7/926.full.pdf |
标签: |
添加标签
没有标签, 成为第一个标记此记录!
|
成为第一个发表评论!